跳至主要内容
临床试验/IRCT20171004036562N2
IRCT20171004036562N2已完成未知

Assessment of fractional co2 laser effect in treatment of women with vuluvaginal atrophy in Emam Khomeini hospital

Tehran University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 no limit(—)
性别
Female

入选标准

  • one or more symptoms of VVA (e.g., vaginal discharge, itching, dyspareunia, dryness and urge urinary incontinence).
  • no menstruation for = 12 months.
  • not using local or systemic estrogen therapy.
  • wishing to be sexual active.

排除标准

  • : use of hormone replacement therapy (systemic or local) up to 6 month before entry to the study.
  • pelvic organ prolapse stage > 2 (according to POP-Q system).
  • active genital infections.
  • acute or recurrent urinary tract infection.
  • use of any vaginal lubricants.
  • moisturizers or local preparations within 30 days before entry to the study.
  • psychiatric disorders which could interfere with informed consent.
  • any chronic disease that could interfere with study compliance.
  • abnormal uterine bleeding which has no exact diagnosis.
  • malignancies of urogenital.

研究者

相似试验